Yale School of Medicine student Priscilla Oluwakemi Badusi, Class of 2028, earned first place in the medical therapy category of the Society for Clinical Vascular Surgery (SCVS) 2026 Karmody ePoster Competition for her abstract, “Glycemic Control in Patients With Diabetes Undergoing Lower Extremity Revascularization.” She was later invited to give a podium presentation at the SCVS 53rd Annual Symposium in San Diego.
Badusi, the study’s first author, is mentored by Associate Professor Cassius Iyad Ochoa Chaar, MD, MPH, MS, and is a member of the Yale Vascular and Endovascular Surgery Interest Group (VESIG). She is completing her surgical rotation in Yale’s Surgical Approach to the Patient (SAP) clerkship.
“Oluwakemi did an excellent job presenting a controversial topic related to the care of diabetic patients with peripheral arterial disease,” says Chaar. “Her findings, based on Yale institutional data, were consistent with prior work we published using the BEST-CLI multicenter trial while also providing additional unique insights. Her work illustrates the talent of our medical students and the impact they can have at a national level.”
Badusi’s study looked at outcomes in 1,345 people with diabetes who had lower extremity revascularization and found that preoperative hemoglobin A1C levels were not linked to long-term mortality, major adverse limb events, or major adverse cardiovascular events. However, the analysis found that insulin use was an independent predictor of mortality and cardiovascular risk, providing important insights into perioperative risk for people with peripheral arterial disease.
The recognition highlights Yale’s strength in student scholarship, mentorship, translational vascular research, and advancing evidence-based care for complex patients.